Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
02 Jun 2022 - BluGlass Limited (ASX:BLG) Executive Chair James Walker provides an update on the company, discussing new staff and developments at BluGlass' manufacturing facility in Silicon Valley.
30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.
18 Nov 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses to the current economic climate, inflation, and government and central bank reactions.
06 May 2020 - Acorn Capital Investment Fund Ltd. (ASX: ACQ) Head of Research and Portfolio Manager for the Consumer Discretionary, Consumer Staples and Information Technology sectors, Robert Bruce talks about the listed investment company, the fund’s composition and outlook for the next 6 months and longer term.
16 Oct 2023 - BluGlass Limited (ASX:BLG) CEO Jim Haden discusses the company's being named a hub member of the US Department of Defense's Microelectronics Commons.
23 June 2020 - Renergen Limited (ASX:RLT) Managing Director Stefano Marani talks about the significance of the company's marketing and distribution agreement with Total South Africa for LNG from Phase 1 of its project.
25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Cristian Moreno, Managing Director of Torque Metals (ASX:TOR).
25 Nov 2020 - Melbana Energy (ASX:MAY) Executive Chairman Andrew Purcell provides an update on its portfolio with particular focus on its onshore Cuban project Block 9, the potential size of the field, drilling program and funding.